share_log

賽生藥業：根據《收購守則》規則22作出的交易披露

SCICLONE PHARMA: Disclosure of Dealings under Rule 22 of the Takeovers Code

Hong Kong Stock Exchange ·  Apr 17 05:27
Summary by Moomoo AI
赛生药业（SCICLONE PHARMA）於2024年4月16日宣布，其全資子公司SciClone Option Management Limited通過協議安排進行了股份交易，涉及私有化過程。該子公司於2024年4月8日賣出20,000股赛生药业股份，每股價格為1.6562美元，交易後持股量為16,591,000股，佔公司已發行股份的2.6429%。此次股份轉讓是為了滿足根據公司2018年6月24日批准的購股權激勵計劃及2021年1月22日股東決議案採納的首次公開發售後受限制股份單位計劃的條款，SciClone Option Management Limited作為賽生信託的受託人行使了相應的購股權。
赛生药业（SCICLONE PHARMA）於2024年4月16日宣布，其全資子公司SciClone Option Management Limited通過協議安排進行了股份交易，涉及私有化過程。該子公司於2024年4月8日賣出20,000股赛生药业股份，每股價格為1.6562美元，交易後持股量為16,591,000股，佔公司已發行股份的2.6429%。此次股份轉讓是為了滿足根據公司2018年6月24日批准的購股權激勵計劃及2021年1月22日股東決議案採納的首次公開發售後受限制股份單位計劃的條款，SciClone Option Management Limited作為賽生信託的受託人行使了相應的購股權。
SCICLONE PHARMA announced on 16 April 2024 that SciClone Option Management Limited, its wholly-owned subsidiary, has entered into an agreed share transaction involving the privatization process. On April 8, 2024, the subsidiary sold 20,000 shares of Sai Soho Pharmaceuticals at a price of $1.6562 per share and a post-transaction holding of 16,591,000 shares representing 2.6429% of the company's issued shares. This transfer of shares is in order to comply with the terms of the restricted share unit plan approved by the Company on 24 June 2018 and the initial public offering of restricted stock units under the Company's share incentive plan approved on 24 June 2018 and the shareholders' resolution of 22 January 2021. SciClone Option Management Limited exercised the corresponding share option as a trustee of the Sai Sai Trust.
SCICLONE PHARMA announced on 16 April 2024 that SciClone Option Management Limited, its wholly-owned subsidiary, has entered into an agreed share transaction involving the privatization process. On April 8, 2024, the subsidiary sold 20,000 shares of Sai Soho Pharmaceuticals at a price of $1.6562 per share and a post-transaction holding of 16,591,000 shares representing 2.6429% of the company's issued shares. This transfer of shares is in order to comply with the terms of the restricted share unit plan approved by the Company on 24 June 2018 and the initial public offering of restricted stock units under the Company's share incentive plan approved on 24 June 2018 and the shareholders' resolution of 22 January 2021. SciClone Option Management Limited exercised the corresponding share option as a trustee of the Sai Sai Trust.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more